These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 12568499

  • 1. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
    Disse B.
    Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ.
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK.
    Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
    [Abstract] [Full Text] [Related]

  • 6. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA, Donaldson GC.
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mucus-controlling agents: past and present.
    King M, Rubin BK.
    Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882
    [Abstract] [Full Text] [Related]

  • 11. Epidemiological studies in mucus hypersecretion.
    Vestbo J.
    Novartis Found Symp; 2002 Dec; 248():3-12; discussion 12-9, 277-82. PubMed ID: 12568485
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluating the efficacy of mucoactive aerosol therapy.
    Fuloria M, Rubin BK.
    Respir Care; 2000 Jul; 45(7):868-73. PubMed ID: 10926385
    [Abstract] [Full Text] [Related]

  • 16. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
    Del Donno M, Olivieri D.
    Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
    [Abstract] [Full Text] [Related]

  • 17. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A.
    Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.